Understanding Lexapro’s Side Effects

By

Editorial Team

|

December 12, 2024

Woman reading medication instructions for Lexapro® (escitalopram) before taking the medication, highlighting the importance of understanding its side effects and safe usage.

Medical Review by Jennie Stanford, MD, FAAFP, DipABOM

Summary

  • Lexapro® (escitalopram) is a prescription antidepressant used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD) by balancing serotonin levels in the brain.
  • Common side effects include insomnia, sexual dysfunction, increased sweating, fatigue, and nausea, especially during the first few weeks as your body adjusts.
  • Serious side effects that need immediate medical attention include suicidal thoughts, signs of mania, seizures, sudden vision problems, unusual bleeding, and serotonin syndrome.
  • Contact your healthcare provider if you notice any new or worsening symptoms to manage side effects and adjust your treatment if needed.

Here’s what you need to know as you start taking Lexapro®

Lexapro® (escitalopram) is a prescription antidepressant that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). It’s commonly used to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD) by helping to balance serotonin levels in the brain.

Lexapro® can improve your mood, energy levels, and balances your emotions while reducing anxiety and stress. But it can also come with side effects that you should understand before taking it.

In this article, we’ll dive deeper into Lexapro®’s side effects, and explain why they happen, how they can affect your body, and when to seek help from a healthcare professional.

Common side effects

Side effects can occur with Lexapro®, especially when you first start taking the medication. As your body adjusts, you may notice a variety of symptoms ranging from mild to more noticeable.

These side effects are typically most prominent during the first few weeks of treatment as your body adapts to changes in serotonin levels. These are the most common side effects of Lexapro®

Insomnia

Insomnia is when you have trouble falling asleep, staying asleep, or getting good quality sleep, which leads to problems during the day.

Increasing serotonin levels with medications, like Lexapro® and other SSRIs, can disrupt your sleep because serotonin promotes wakefulness, making it harder for you to fall asleep. Serotonin also helps produce melatonin, the hormone that regulates the sleep-wake cycle. When serotonin levels change, it can affect melatonin production, making it harder to sleep as well.

People with depression or anxiety often have sleep issues, which are key symptoms in diagnosing both major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram has been found to be more effective than other SSRIs at improving sleep problems.

Sexual dysfunction

Sexual dysfunction includes issues like ejaculatory delay (taking longer to ejaculate), erectile dysfunction, lower sex drive, and anorgasmia (making it harder to have an orgasm).

When you take SSRIs, the higher serotonin levels block the brain’s dopamine and norepinephrine pathways, which are important for desire and arousal. Most serotonin is found outside the brain, and when levels are higher, it can reduce sensations in the genitals.

This can lead to erectile dysfunction, low vaginal lubrication, and orgasm problems. Serotonin also blocks the production of nitric oxide, which helps relax blood vessels. Without this, there’s less blood flow to your genitals, which can affect sexual function.

In clinical trials, 12% of males taking Lexapro® had ejaculatory delay, compared to 1% with a placebo. Erectile dysfunction affected 2% of males versus 1% on placebo. For females, 3% had trouble reaching orgasm, compared to less than 1% on placebo. In both males and females, 3% experienced a decrease in libido.

Increased sweating

Excessive sweating is a common and uncomfortable side effect of using antidepressants, with about 10% of people on SSRIs experiencing it. The exact cause isn’t fully understood, but it’s believed that SSRIs affect serotonin levels in the hypothalamus, the part of your brain that controls your body temperature. This serotonin change may lead to your body sweating more than it should.

Fatigue & tiredness

Fatigue is the feeling of being both physically and mentally tired. Fatigue from SSRIs like Lexapro® can happen in two ways:

  • SSRIs can disrupt your sleep-wake cycle by raising serotonin levels, leading to many nights of bad sleep and daytime tiredness.
  • Serotonin may interfere with dopamine and your body’s stress response, which can also cause fatigue.

Nausea

When taking Lexapro®, you may experience nausea because it increases serotonin levels in your body. Approximately 90% of your serotonin is stored in your gastrointestinal system, which has many cells that respond to serotonin. Higher serotonin levels in this area can upset your stomach and cause nausea.

Serious side effects

Suicidal thoughts or attempts

Young people aged 24 and under have a higher risk of suicidal thoughts and behaviors, especially in the first few months of starting an SSRI like Lexapro® or after a dose change. The exact reason for this is not fully understood.

Studies show that for those under 18, there are 1.4% more cases of suicidal thoughts and behaviors compared to those on a placebo. For those aged 18-24, the increase is 0.5%.

Mania

Mania is a time of at least one week when a person has a big change in behavior that greatly affects their daily life.

Signs of mania include:

  • Increased talkativeness and rapid speech
  • Less need for sleep
  • Racing thoughts and distractibility
  • Upbeat and over-excited
  • Mood swings, impulsivity & irritability

In clinical trials, only 0.1% of people taking Lexapro® experienced mania or hypomania compared to those on a placebo. However, if you have bipolar disorder, the risk of antidepressant-induced mania can be higher, ranging from 20-40%.

Before starting Lexapro®, it’s important you check for any personal or family history of bipolar disorder. Many people with bipolar disorder first show depressive symptoms, so you could have an underlying bipolar disorder.

Typically, manic symptoms from antidepressants appear within a few days to 2 weeks after starting the medication and usually resolve within 2 weeks after stopping it.

Seizures

Lexapro® hasn’t been tested in people with seizure disorders, but some cases of convulsions have been reported. Generally, the risk of seizures with antidepressants is low and mostly linked to very high doses or overdoses.

If you have a history of seizures or epilepsy, you may still be able to use Lexapro® safely with careful monitoring by your healthcare provider. Always be transparent with your provider about the medication you are taking.

Angle-closure glaucoma

Angle-closure glaucoma is a serious eye problem where pressure builds up quickly inside your eye because the fluid that keeps your eyes nourished can’t drain properly. SSRIs can cause your pupils to dilate (get larger), which can lead to the iris (the colored part of your eye) blocking the eye’s drainage system.

This blockage causes the fluid to build up, increasing eye pressure, and potentially leading to permanent damage if not treated quickly.

Angle-closure glaucoma often comes on suddenly and can cause severe symptoms, including:

  • Intense eye pain
  • Blurred or reduced vision
  • Rainbow-colored halos around lights
  • Nausea and vomiting

Increased risk of bleeding

Taking SSRIs like Lexapro® can raise your risk of unusual bleeding, especially if you’re also using aspirin, NSAIDs, antiplatelet drugs, or anticoagulants like warfarin. SSRIs increase serotonin levels in your brain by blocking its reabsorption, but they also block serotonin reabsorption in platelets—blood cells that help with clotting.

Serotonin helps platelets to stick together to form clots. When serotonin levels in platelets become low, they are unable to clot together, leading to a higher risk of abnormal bleeding.

Hyponatremia

Hyponatremia is a condition where the sodium levels in your blood get too low. This can sometimes happen when taking SSRIs like Lexapro®, especially if you have syndrome of inappropriate antidiuretic hormone secretion (SIADH), which causes the body to hold onto water and dilute sodium. Elderly people, females, and those on diuretics have a higher risk.

Symptoms of hyponatremia include:

  • Headache
  • Trouble concentrating
  • Memory problems
  • Confusion
  • Weakness and unsteadiness which may lead to falls

In more severe cases, it can cause hallucinations, fainting, seizures, coma, or even life-threatening issues.

Hyponatremia related to SSRIs usually starts within the first two weeks of treatment and is not related to the dose. Sodium levels normally return to normal within 2–20 days after stopping the medication.

Serotonin syndrome

Serotonin syndrome is a serious condition that can be life-threatening. It happens when there’s too much serotonin in your brain, often due to taking medications that boost serotonin levels, especially if you’re using more than one such medication. It can also occur if you’re on a medication that affects how serotonin is broken down, like MAOIs, which prevent serotonin from being used up or removed properly.

Keep an eye out for these symptoms of serotonin syndrome:

  • Agitation, hallucinations, confusion, or delirium
  • Fast heart rate or increased blood pressure
  • Sweating and/or high fever
  • Stiff muscles or tremors
  • Seizures
  • Nausea, vomiting, and/or diarrhea

When to seek medical help

If you have any new or worsening symptoms while taking Lexapro®, let your healthcare provider know right away. This includes common side effects like trouble sleeping, sexual issues, sweating more than usual, and feeling fatigued or nauseous. Your healthcare provider can help manage these side effects and adjust your treatment if needed.

For serious side effects, such as thoughts of self-harm, symptoms of mania, seizures, sudden vision problems, unusual bleeding, or signs of serotonin syndrome—seek emergency care immediately.

Find your Lexapro® support system with Lemonaid Health

While side effects from Lexapro® can occur, staying in communication with your healthcare provider is the best way to help you manage them effectively. Side effects often improve over time, but if you experience anything serious, seek help immediately. It’s important to inform your healthcare provider about any side effects you notice.

Our team at Lemonaid Health can help. Set up a virtual visit with a qualified US-based health professional who can help you understand any side effects and find appropriate solutions, including FDA-approved medication in clinically indicated cases.

Lexapro® is a registered trademark of H. Lundbeck A/S.

  1. Landy, K., Rosani, A., & Estevez, R. (2023). Escitalopram. PubMed; StatPearls Publishing; Accessed Sept 16 2024 at https://www.ncbi.nlm.nih.gov/books/NBK557734/
  2. Lochmann, D., & Richardson, T. (2019). Selective Serotonin Reuptake Inhibitors. Handbook of experimental pharmacology, 250, 135–144. https://doi.org/10.1007/164_2018_172 
  3. Polychroniou, P. E., Mayberg, H. S., Craighead, W. E., Rakofsky, J. J., Aponte Rivera, V., Haroon, E., & Dunlop, B. W. (2018). Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults. Behavioral sciences (Basel, Switzerland), 8(7), 64. https://doi.org/10.3390/bs8070064
  4. AbbVie. Lexapro® (escitalopram oxalate) [package insert]. U.S. Food and Drug Administration website. Accessed Sept 16 2024 at https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021323s058lbl.pdf
  5. Morin, C. M., & Jarrin, D. C. (2022). Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep medicine clinics, 17(2), 173–191. https://doi.org/10.1016/j.jsmc.2022.03.003
  6. Monti J. M. (2011). Serotonin control of sleep-wake behavior. Sleep medicine reviews, 15(4), 269–281. Accessed Sept 16 2024 at https://doi.org/10.1016/j.smrv.2010.11.003
  7. Zbozinek, T. D., Rose, R. D., Wolitzky-Taylor, K. B., Sherbourne, C., Sullivan, G., Stein, M. B., Roy-Byrne, P. P., & Craske, M. G. (2012). Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depression and anxiety, 29(12), 1065–1071. Accessed Sept 16 2024 at https://doi.org/10.1002/da.22026
  8. Stein, D. J., & Lopez, A. G. (2011). Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder. Advances in therapy, 28(11), 1021–1037. Accessed Sept 16 2024 at https://doi.org/10.1007/s12325-011-0071-8
  9. Higgins, A., Nash, M., & Lynch, A. M. (2010). Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug, healthcare and patient safety, 2, 141–150. Accessed Sept 16 2024 at https://doi.org/10.2147/DHPS.S7634
  10. Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016). The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature. Psychotherapy and psychosomatics, 85(5), 270–288. Accessed Sept 16 2024 at https://doi.org/10.1159/000447034
  11. Voronova I. P. (2021). 5-HT Receptors and Temperature Homeostasis. Biomolecules, 11(12), 1914. Accessed Sept 16 2024 at https://doi.org/10.3390/biom11121914
  12. Marin, H., & Menza, M. A. (2004). Specific treatment of residual fatigue in depressed patients. Psychiatry (Edgmont), 1(2), 12–18. Accessed Sept 16 2024 at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012615/
  13. McManis, P. G., & Talley, N. J. (1997). Nausea and Vomiting Associated With Selective Serotonin Reuptake Inhibitors. CNS Drugs, 8(5), 394–401. Accessed Sept 16 2024 at https://doi.org/10.2165/00023210-199708050-00005
  14. ‌Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010). Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta psychiatrica Scandinavica, 121(6), 404–414. https://doi.org/10.1111/j.1600-0447.2009.01514.x
  15. Lim, C. J., Leckman, J. F., Young, C., & Martin, A. (2005). Antidepressant-induced manic conversion: a developmentally informed synthesis of the literature. International review of neurobiology, 65, 25–52. Accessed Sept 16 2024 at https://doi.org/10.1016/S0074-7742(04)65002-1 
  16. Steinert, T., & Fröscher, W. (2018). Epileptic Seizures Under Antidepressive Drug Treatment: Systematic Review. Pharmacopsychiatry, 51(4), 121–135. Accessed Sept 16 2024 at https://doi.org/10.1055/s-0043-117962
  17. Chen, V. C., Ng, M. H., Chiu, W. C., McIntyre, R. S., Lee, Y., Lin, T. Y., Weng, J. C., Chen, P. C., & Hsu, C. Y. (2017). Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study. PloS one, 12(3), e0173005. https://doi.org/10.1371/journal.pone.0173005
  18. Seitz, D. P., Campbell, R. J., Bell, C. M., Gill, S. S., Gruneir, A., Herrmann, N., Newman, A. M., Anderson, G., & Rochon, P. A. (2012). Short-term exposure to antidepressant drugs and risk of acute angle-closure glaucoma among older adults. Journal of clinical psychopharmacology, 32(3), 403–407. Accessed Sept 16 2024 at https://doi.org/10.1097/JCP.0b013e31825420a1
  19. Engler, J., Filliter, C., Montastruc, F., Abenhaim, H., Rej, S., & Renoux, C. (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. Journal of affective disorders, 350, 813–821. Accessed Sept 16 2024 at https://doi.org/10.1016/j.jad.2024.01.163
  20. Tomar, L. K., Patra, P., & Nigam, A. (2021). A study to understand the pattern of hyponatremia in patients using selective serotonin reuptake inhibitors and serotonin dopamine antagonists. Industrial psychiatry journal, 30(1), 113–117. Accessed Sept 16 2024 at https://doi.org/10.4103/ipj.ipj_146_20
  21. Rawal, G., Kumar, R., & Yadav, S. (2017). Severe hyponatremia associated with escitalopram. Journal of family medicine and primary care, 6(2), 453–454. Accessed Sept 16 2024 at https://doi.org/10.4103/2249-4863.220043
  22. Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International journal of tryptophan research : IJTR, 12, 1178646919873925. https://doi.org/10.1177/1178646919873925

By

Editorial Team

|

December 12, 2024

This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment or medication.